Dual receptor agonist
Acts on both GIP and GLP-1 receptors rather than only one pathway.
Lennox / RxProduct to be confirmed / Prescription-specific
Education guide / exact product unconfirmed / Prescription-specific
Tirzepatide.Identify the product before comparing outcomes.
Tirzepatide activates GIP and GLP-1 receptors. FDA-approved branded products have specific labels; a compounded product is different and is not FDA-approved.
The repository does not confirm whether Lennox’s exact model uses an FDA-approved branded medication or an individually compounded product. This page therefore remains education-first and does not publish unverified pricing.
Availability
Education guideThis page does not present the product as available to purchase
- Licensed provider review
- Prescription required
- Ongoing clinical support
Education only · Provider evaluation required · Prescription not guaranteed · Compounded drugs are not FDA-approved or generic equivalents · Exact product and dosing are prescription-specific · Individual results vary
What is Tirzepatide?
One ingredient name can describe legally different products.
Tirzepatide is the active ingredient in FDA-approved branded products with specific indications, labeling, manufacturing, and review.
A compounded tirzepatide product is not a generic equivalent and is not reviewed by FDA for safety, effectiveness, or quality before marketing. Exact product identity must be clear before discussing results.
Must be identified
Brand, compounder, route, formulation, and indication cannot be inferred from the ingredient name or image.
Individualized care
Dose changes depend on the prescribed product, response, and tolerability.
Product distinctions
Facts to confirm before any offer is published.
- 01
Whether the product is FDA-approved branded medication or compounded
- 02
The exact indication, formulation, route, dose, and pharmacy
- 03
Why a compounded drug is not a generic brand equivalent
- 04
Current state and federal availability requirements
- 05
Product-specific risks, instructions, and monitoring
- 06
What evidence applies to the exact product being prescribed
How it may work
Two hormone pathways. One personalized plan.
Tirzepatide activates both GIP and GLP-1 receptors. That mechanism helps explain labeled effects of approved products, but it does not establish that an unconfirmed compounded product is equivalent or will produce the same result.
Activates two pathways
Tirzepatide activates receptors for GIP and GLP-1, hormones involved in metabolic signaling.
May increase fullness
It can affect appetite signals, which may help some people eat less when paired with a care plan.
Slows stomach emptying
This effect can influence fullness, blood sugar, side effects, and absorption of some oral medicines.
Curious about the science?
Explore tirzepatide research and prescribing information.
Explore research related to this treatment and the biological processes it is designed to support.
Lennox online care
Three clear steps.
One care team.
AvailabilityEducation guideThis page does not present the product as available to purchase.
- 01
Complete your health assessment
Share your health history, medicines, allergies, goals, and prior weight-care treatments in a private online form.
- 02
Get a licensed provider review
A provider decides whether tirzepatide is appropriate and discusses the exact product. A prescription is not guaranteed.
- 03
Receive ongoing care
If prescribed, use only as labeled and stay in contact about side effects, questions, and follow-up.
Safety first
Know what to ask.
Tirzepatide has important risks and is not right for everyone. Animal studies found thyroid C-cell tumors; it is unknown whether this occurs in humans. Do not use it with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Review severe stomach symptoms and pancreatitis warning signs
- Discuss gallbladder, kidney, allergy, and low-blood-sugar risks
- Share all medicines, pregnancy plans, and upcoming procedures
- Get urgent help for a serious allergic reaction or severe symptoms
Common questions
FDA-approved tirzepatide products have specific indications, including certain adults with type 2 diabetes and certain adults with obesity or overweight plus a weight-related condition. The intended use depends on the exact product and your provider's evaluation.
Do not infer a weekly dose from the vial strength or this page. Dose, concentration, injection volume, timing, and any changes must come from your prescription label and provider.
Common effects with FDA-approved tirzepatide products include nausea, diarrhea, vomiting, constipation, stomach pain, and indigestion. Some reactions can be serious, so review the full safety information with your provider.
Yes. It slows stomach emptying and may affect absorption of oral medicines. The risk of low blood sugar can rise with insulin or certain diabetes medicines. Share every medicine and supplement with your provider.
Not necessarily. Tirzepatide is the active ingredient in those FDA-approved brand products, but the product dispensed depends on your prescription. Ask your provider and pharmacy to identify it. Compounded drugs are not FDA-approved.
Your next step
See if Tirzepatide care may fit you.
This guide is educational and does not present this treatment as available to purchase.